These pharmacological properties of dihydropyridine-class calcium channel blockers were evident in the Ritz et al. study. By documenting the use of centrally active calcium channel blockers in a ...

Groundbreaking study of 542,000 women shows that consuming calcium daily may lower colorectal cancer risk by 17%. Learn what ...

Soft gel pills are projected to dominate the calcium supplement market in Japan, accounting for 49.8% of the market share in ...

A team of UVM scientists led by University Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., from the ...